HOME Top Market Reports Aptamers Market by Type (DNA, RNA, XNA), Application (Diagnostics, Therapeutics, R&D), Technology (SELEX, Other Technologies) & by End Users (Academic Research Institutes, Biotechnology & Pharmaceutical Companies, CRO) - Global Forecast to 2020

Aptamers Market by Type (DNA, RNA, XNA), Application (Diagnostics, Therapeutics, R&D), Technology (SELEX, Other Technologies) & by End Users (Academic Research Institutes, Biotechnology & Pharmaceutical Companies, CRO) - Global Forecast to 2020

By: marketsandmarkets.com
Publishing Date: June 2015
Report Code: BT 3550

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global aptamers market is expected to reach $244.93 Million by 2020 from $107.56 Million in 2015, at a CAGR of 17.89%. Aptamers bind to target protein, lipid, or nucleic acid molecules with a high degree of specificity. Aptamers can be generated rapidly and applied in the specific detection, inhibition, and characterization of proteins. These can be used as pharmaceutical leads, detection reagents, and functional proteomic levels (with small molecules, antibodies, or other aptamers). The scope of this market report includes DNA-, RNA-, and XNA-based aptamers used for research applications.

The major drivers for the market include a strong trend of R&D investments in biotechnology and pharmaceutical industries, patent expiration of systematic evolution of ligands by exponential enrichment technology (SELEX), technological advancements, and the low cost and high efficiency of aptamers in binding to large molecules as compared to antibodies.

In this report, the global aptamers market is segmented based on type, application, technology, end user, and geography. Based on type, the market is segmented into DNA-based aptamers, RNA-based aptamers, and XNA-based aptamers. Based on applications, the market is segmented into diagnostics, therapeutics development, R&D, and other applications. On the basis of technology the market is segmented into SELEX and other technologies. The end users for this market are academic and government research institutes, biotechnology and pharmaceutical companies, contract research organizations (CROs), and other end users. Based on geography, the global market is segmented into the Americas, Europe, Asia, and the Rest of the World (RoW).

The major players in aptamers market include AM Biotechnologies, LLC (U.S.), Aptagen, LLC (U.S.), Aptamer Sciences, Inc. (South Korea), Aptamer Solutions Ltd. (U.K.), Aptus Biotech S.L. (Spain), Base Pair Biotechnologies, Inc. (U.S.), NeoVentures Biotechnology, Inc. (Canada), SomaLogic, Inc. (U.S.), TriLink BioTechnologies, Inc. (U.S.), and Vivonics, Inc. (U.S.).

Scope of the Report

This research report categorizes the global market into the following segments and subsegments:

Global Aptamers Market, by Type

  • DNA-Based Aptamers
  • RNA-Based Aptamers
  • XNA-Based Aptamers

Global Aptamers Market, by Application

  • Diagnostics
  • Therapeutics Development
  • Research and Development
  • Other Applications

Global Aptamers Market, by Technology

  • SELEX
  • Other Technologies

Global Aptamers Market, by End User

  • Academic and Government Research Institutes
  • Biotechnology and Pharmaceutical Companies
  • Contract Research Organizations
  • Other End Users

Global Aptamers Market, by Geography

  • Americas
    • U.S.
    • Canada
    • Latin America
  • Europe
  • Asia
  • Rest of the World

Table of Contents

1 Introduction (Page No. - 10)
    1.1 Objectives of the Study
    1.2 Market Definition
           1.2.1 Market Covered
           1.2.2 Years Considered in the Report
    1.3 Currency
    1.4 Stakeholders
    1.5 Limitations

2 Research Methodology (Page No. - 13)
    2.1 Market Size Estimation
    2.2 Market Breakdown and Data Triangulation
           2.2.1 Key Data From Secondary Sources
           2.2.2 Key Data From Primary Sources
           2.2.3 Assumptions for the Study

3 Executive Summary (Page No. - 19)

4 Premium Insights (Page No. - 23)
    4.1 Lucrative Opportunities in the Global Aptamers Market
    4.2 Life Cycle Analysis, By Region

5 Market Overview (Page No. - 27)
    5.1 Introduction
    5.2 Market Segmentation
           5.2.1 By Type
           5.2.2 By Application
           5.2.3 By Technology
           5.2.4 By End User
    5.3 Market Dynamics
           5.3.1 Drivers
                    5.3.1.1 Strong Trend of R&D Investments in Biotechnology and Pharmaceutical Companies
                    5.3.1.2 Technological Advancements
                    5.3.1.3 Patent Expiration of Selex
                    5.3.1.4 Low-Cost and High-Efficiency as Compared to Antibodies
           5.3.2 Restraints
                    5.3.2.1 Low Market Acceptance
                    5.3.2.2 Lack of Trained Professionals
           5.3.3 Opportunities
                    5.3.3.1 Applications in Other Industries

6 Aptamers Market, By Type (Page No. - 35)
    6.1 Introduction
    6.2 DNA-Based Aptamers
    6.3 RNA-Based Aptamers
    6.4 XNA-Based Aptamers

7 Aptamers Market, By Application (Page No. - 46)
    7.1 Introduction
    7.2 Diagnostics
    7.3 Therapeutics Development
    7.4 Research and Development
    7.5 Other Applications

8 Aptamers Market, By Technology (Page No. - 58)
    8.1 Introduction
    8.2 Selex
    8.3 Other Technologies

9 Aptamers Market, By End User (Page No. - 65)
    9.1 Introduction
    9.2 Academic and Government Research Institutes
    9.3 Biotechnology and Pharmaceutical Companies
    9.4 Contract Research Organizations
    9.5 Other End Users

10 Global Aptamers Market, By Region (Page No. - 76)
     10.1 Introduction
     10.2 Americas
             10.2.1 U.S.
             10.2.2 Canada
             10.2.3 Latin America
     10.3 Europe
     10.4 Asia
     10.5 Rest of the World (RoW)

11 Competitive Landscape (Page No. - 103)
     11.1 Introduction
     11.2 Competitive Situation and Trends
             11.2.1 Agreements, Collaborations, Expansions, and Partnerships
             11.2.2 Contracts, Development Agreements, Funding, Grants, and Rewards
             11.2.3 New Product Launches
             11.2.4 Other Developments

12 Company Profiles (Page No. - 108)
     12.1 Introduction
     12.2 Am Biotechnologies, LLC
             12.2.1 Business Overview
             12.2.2 Product and Services
             12.2.3 News/Events
     12.3 Aptagen, LLC
             12.3.1 Business Overview
             12.3.2 Product and Services
             12.3.3 News/Events
     12.4 Aptamer Sciences Inc.
             12.4.1 Business Overview
             12.4.2 Product and Services
             12.4.3 News/Events
     12.5 Aptamer Solutions Ltd.
             12.5.1 Business Overview
             12.5.2 Product and Services
             12.5.3 News/Events
     12.6 Aptus Biotech S.L.
             12.6.1 Business Overview
             12.6.2 Product and Services
             12.6.3 News/Events
     12.7 Base Pair Biotechnologies, Inc.
             12.7.1 Business Overview
             12.7.2 Product and Services
             12.7.3 News/Events
     12.8 Neoventures Biotechnology Inc.
             12.8.1 Business Overview
             12.8.2 Product and Services
             12.8.3 News/Events
     12.9 Somalogic, Inc.
             12.9.1 Business Overview
             12.9.2 Product and Services
             12.9.3 News/Events
     12.10 Trilink Biotechnologies, Inc.
             12.10.1 Business Overview
             12.10.2 Product and Services
             12.10.3 News/Events
     12.11 Vivonics, Inc.
             12.11.1 Business Overview
             12.11.2 Product and Services
             12.11.3 News/Events

13 Appendix (Page No. - 121)
     13.1 Insights of Industry Experts
     13.2 Discussion Guide
     13.3 Introducing RT: Real-Time Market Intelligence
     13.4 Available Customizations
     13.5 Related Reports


List of Tables (74 Tables)

Table 1 Aptamers Market Summary
Table 2 Increasing R&D Investments By Biotechnology and Pharmaceutical Companies is Propelling the Growth of the Aptamers Market
Table 3 Low Market Acceptance of Aptamers as Compared to Antibodies Would Restrict the Market Growth
Table 4 Applications in Other Industries Present Significant Growth Opportunities for the Aptamers Market
Table 5 Aptamers Market Size, By Type, 20132020 ($Million)
Table 6 DNA-Based Aptamers Generated Against Various Ligands
Table 7 DNA-Based Aptamers Market Size, By Region, 20132020 ($Million)
Table 8 Americas: DNA-Based Aptamers Market Size, By Country, 20132020 ($Million)
Table 9 RNA-Based Aptamers Generated Against Various Ligands
Table 10 RNA-Based Aptamers Market Size, By Region, 20132020 ($Million)
Table 11 Americas: RNA-Based Aptamers Market Size, By Country, 20132020 ($Million)
Table 12 Common Chemical Modifications of Aptamers for Tumor Targeting
Table 13 XNA-Based Aptamers Market Size, By Region, 20132020 ($Million)
Table 14 Americas: XNA-Based Aptamers Market Size, By Country, 20132020 ($Million)
Table 15 Aptamers Market Size, By Application, 20132020 ($Million)
Table 16 List of RNA Aptamer Sequences and Their Targets for Targeted Therapy and Their Diagnostic Applications
Table 17 Aptamers Market Size for Diagnostics Application, By Region, 20132020 ($Million)
Table 18 The Americas: Aptamers Market Size for Diagnostics, By Region, 20132020 ($Million)
Table 19 Status of Aptamer Therapeutics Undergoing Clinical Trails
Table 20 Aptamers Market Size for Therapeutics Development Application, By Region, 20132020 ($Million)
Table 21 Americas: Aptamers Market Size for Therapeutics Development, By Region, 20132020 ($Million)
Table 22 Aptamers Market Size for Research and Development, By Region, 20132020 ($Million)
Table 23 Americas: Aptamers Market Size for Research and Development, By Region, 20132020 ($Million)
Table 24 Aptamers Market Size for Other Applications, By Region, 20132020 ($Million)
Table 25 Americas: Aptamers Market Size for Other Applications, By Region, 20132020 ($Million)
Table 26 Aptamers Market Size, By Technology, 20132020 ($Million)
Table 27 List of Modifications to the Selex Process and Their Descriptions
Table 28 Aptamers Market Size for Selex, By Region, 20132020 ($Million)
Table 29 Americas: Aptamers Market Size for Selex, By Region, 20132020 ($Million)
Table 30 Aptamers Market Size for Other Technologies, By Region, 20132020 ($Million)
Table 31 Americas: Aptamers Market Size for Other Technologies, By Region, 20132020 ($Million)
Table 32 Aptamers Market Size, By End User, 20132020 ($Million)
Table 33 Aptamers Market Size for Academic and Government Research Institutes, By Region, 20132020 ($Million)
Table 34 Americas: Aptamers Market Size for Academic and Government Research Institutes, By Country, 20132020 ($Million)
Table 35 Aptamers Market Size for Biotechnology and Pharmaceutical Companies, By Region, 20132020 ($Million)
Table 36 Americas: Aptamers Market Size for Biotechnology and Pharmaceutical Companies, By Country, 20132020 ($Million)
Table 37 Aptamers Market Size for Cros, By Region, 20132020 ($Million)
Table 38 Americas: Aptamers Market Size for Cros, By Country, 20132020 ($Million)
Table 39 Aptamers Market Size for Other End Users, By Region, 20132020 ($Million)
Table 40 Americas: Market Size for Other End Users, By Country, 20132020 ($Million)
Table 41 Aptamers Market Size, By Region, 20132020 ($Million)
Table 42 Americas: Aptamers Market Size, By Country, 20132020 ($Million)
Table 43 Americas: Market Size, By Type, 20132020 ($Million)
Table 44 Americas: Market Size, By Application, 20132020 ($Million)
Table 45 Americas: Market Size, By Technology, 20132020 ($Million)
Table 46 Americas: Market Size, By End User, 20132020 ($Million)
Table 47 U.S.: Aptamers Market Size, By Type, 20132020 ($Million)
Table 48 U.S.: Market Size, By Application, 20132020 ($Million)
Table 49 U.S.: Market Size, By Technology, 20132020 ($Million)
Table 50 U.S.: Market Size, By End User, 20132020 ($Million)
Table 51 Canada: Aptamers Market Size, By Type, 20132020 ($Million)
Table 52 Canada: Market Size, By Application, 20132020 ($Million)
Table 53 Canada: Market Size, By Technology, 20132020 ($Million)
Table 54 Canada: Market Size, By End User, 20132020 ($Million)
Table 55 Latin America: Aptamers Market Size, By Type, 20132020 ($Million)
Table 56 Latin America: Market Size, By Application, 20132020 ($Million)
Table 57 Latin America: Aptamers Market Size, By Technology, 20132020 ($Million)
Table 58 Latin America: Market Size, By End User, 20132020 ($Million)
Table 59 Europe: Aptamers Market Size, By Type, 20132020 ($Million)
Table 60 Europe: Market Size, By Application, 20132020 ($Million)
Table 61 Europe:  Market Size, By Technology, 20132020 ($Million)
Table 62 Europe: Market Size, By End User, 20132020 ($Million)
Table 63 Asia: Aptamers Market Size, By Type, 20132020 ($Million)
Table 64 Asia: Market Size, By Application, 20132020 ($Million)
Table 65 Asia: Market Size, By Technology, 20132020 ($Million)
Table 66 Asia: Market Size, By End User, 20132020 ($Million)
Table 67 RoW: Aptamers Market Size, By Type, 20132020 ($Million)
Table 68 RoW: Market Size, By Application, 20132020 ($Million)
Table 69 RoW: Market Size, By Technology, 20132020 ($Million)
Table 70 RoW: Market Size, By End User, 20132020 ($Million)
Table 71 Agreements, Collaborations, Expansions, and Partnerships, 20112015
Table 72 Contracts, Development Agreements, Funding, Grants, and Rewards, 20112015
Table 73 New Product Launches, 20112015
Table 74 Other Developments, 20112015


List of Figures (67 Figures)

Figure 1 Aptamers Market
Figure 2 Research Design
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: By Designation and Region
Figure 6 Data Triangulation Methodology
Figure 7 Aptamers Market Size, By Type, 2015 vs 2020 ($Million)
Figure 8 Aptamers Market Size, By Application, 2015 vs 2020 ($Million)
Figure 9 Market Size, By Technology, 2015 vs 2020 ($Million)
Figure 10 Market Size, By End User, 2015 vs 2020 ($Million)
Figure 11 Aptamers Market Size, By Region, 2015 vs 2020 ($Million)
Figure 12 Global Aptamers Market to Witness High Growth During the Forecast Period
Figure 13 Diagnostics Applications to Account for the Largest Market Share in 2015
Figure 14 Europe to Witness Highest Growth Rate From 2015 to 2020
Figure 15 European Market Showcases Lucrative Growth Opportunities
Figure 16 Aptamers Market Segmentation: By Type
Figure 17 Aptamers Market Segmentation: By Application
Figure 18 Market Segmentation: Technology
Figure 19 Market Segmentation: By End User
Figure 20 Strong Trend of R&D Investments By Biotechnology and Pharmaceutical Companies Will Drive the Aptamers Market
Figure 21 New Pharmaceutical Drug Launches (20032013)
Figure 22 Aptamers Market Segmentation, By Type
Figure 23 DNA-Based Aptamers Segment Command the Largest Share of the Aptamers Market, 2015 ($Million)
Figure 24 The Americas to Command the Largest Share of the DNA-Based Aptamers Market By 2020
Figure 25 The Americas to Command the Largest Share of the RNA-Based Aptamers Market in 2015
Figure 26 Europe to Be the Largest and Fastest-Growing Regional Segment of the XNA-Based Aptamers Market By 2020
Figure 27 Aptamers Market, By Application
Figure 28 Diagnostics Application Segment Commands the Largest Share of the Aptamers Market in 2015 ($Million)
Figure 29 Europe, the Fastest-Growing Regional Segment for Diagnostics Applications, 2015 vs 2020 ($Million)
Figure 30 Americas Expected to Be the Largest Regional Segment for Therapeutics Development Application ($Million)
Figure 31 Americas to Dominate the R&D Application Segment in 2015
Figure 32 European Other Applications Segment to Witness Fastest Growth
Figure 33 Aptamers Market Segmentation, By Technology
Figure 34 Aptamers Market, By Technology, 2015 vs 2020 ($Million)
Figure 35 Americas to Command the Largest Share of the Selex Segment By 2020
Figure 36 Europe Will Be the Fastest-Growing Regional Segment for Other Technologies in 2020
Figure 37 Aptamers Market Segmentation, By End User
Figure 38 Aptamers Market Size, By End User, 2015 vs 2020 ($Million)
Figure 39 Public-Sector Research Funding is Driving the Growth of the Academic & Government Research Institutes Market
Figure 40 The Americas Dominate the Aptamers Market for Academic and Government Research Institutes
Figure 41 Number of Biotechnology and Pharmaceutical Patents Granted in 2012, By Region
Figure 42 Biotechnology and Pharmaceutical Companies Segment to Witness the Highest Growth in Europe
Figure 43 The Americas are Expected to Dominate the Aptamers Market for Cros
Figure 44 Europe to Witness Highest Growth in the Aptamers Market for Other End Users in the Forecast Period
Figure 45 Aptamers Market Segmentation, By Region
Figure 46 Americas to Dominate the Global Aptamers Market
Figure 47 Aptamers Market in Europe to Witness the Highest Growth From 2015 to 2020
Figure 48 Americas: Market Snapshot
Figure 49 U.S. to Dominate the Aptamers Market in the Americas
Figure 50 DNA-Based Aptamers to Command the Largest Share of the Aptamers Market in the Americas
Figure 51 Diagnostics Segment to Account for the Largest Share of the Aptamers Applications Market in Americas
Figure 52 Selex Formed the Largest Technology Segment in the Americas
Figure 53 Academic and Government Research Institutes Formed the Largest End-User Segment in the Americas
Figure 54 Europe: Market Snapshot
Figure 55 DNA-Based Aptamers to Command the Largest Share of the European Aptamers Market
Figure 56 Diagnostics Segment to Account for the Largest Share of the Aptamers Applications Market in Europe
Figure 57 Selex Formed the Largest Technology Segment in Europe
Figure 58 Academic and Government Research Institutes Account for the Largest Share of the Aptamers End-Users Market in Europe
Figure 59 DNA-Based Aptamers to Command the Largest Share of the Aptamers Market in Asia
Figure 60 Diagnostics Application Segment to Dominate the Aptamers Market in Asia
Figure 61 Selex Segment to Account for the Largest Share of the Aptamers Technologies Market in Asia
Figure 62 Academic and Government Research Institutes to Account for the Largest Share of the Aptamers End-User Market in Asia
Figure 63 DNA-Based Aptamers to Command the Largest Share of the RoW Aptamers Market
Figure 64 The Diagnostics Application Segment to Command the Largest Share of the Aptamers Market in the RoW Region
Figure 65 The Selex Technology Segment is Expected to Dominate the RoW Aptamers Market in 2015
Figure 66 Academic and Government Research Institutes Segment to Dominate the RoW Market for Aptamers
Figure 67 Growth Strategies: Agreements, Collaborations, Expansions, and Partnerships Was the Key Strategy

The global aptamers market is estimated to be valued at $107.56 Million in 2015, growing at a CAGR of 17.89% to reach $244.93 Million by 2020. Factors such as strong trend of R&D investments in biotechnology and pharmaceutical industries, patent expiration of the systematic evolution of ligands by exponential enrichment technology (SELEX), technological advancements, and the low cost and high efficiency of aptamers in binding to large molecules as compared to antibodies are driving the growth of the market. The increased applications of aptamers in the food and chemicals industries will provide opportunities for market growth.

This report segments the global aptamers market by type, application, technology, and end user. The global aptamers market product segments included in the report comprises DNA-based, RNA-based aptamers, and XNA-based aptamers. In 2015, the DNA-based aptamers segment is expected to account for the largest share of the global market. The applications included in this report are general diagnostics, therapeutics development, R&D, and other applications. In 2015, the diagnostics segment is expected to account for the largest share of the global market.

Based on technology, the aptamers market is categorized into SELEX and other technologies. In 2015, the SELEX segment is expected to account for the largest share of the global market. On the basis of end users, the global market report is segmented into academic and government research institutes, biotechnology and pharmaceutical companies, contract research organizations (CROs), and other end users. In 2015, the academic and government research institutes segment is expected to account for the largest share of the global aptamers market.

The geographic segments included in this report are the Americas, Europe, Asia, and the Rest of the World (RoW). In 2015, the Americas are expected to command the largest share of the global market. Europe is expected to register the highest growth from 2015 to 2020, due to increasing manufacturing in this region.

Major players in the global aptamers market are AM Biotechnologies, LLC (U.S.), Aptagen, LLC (U.S.), Aptamer Sciences, Inc. (South Korea), Aptamer Solutions (U.K.), Ltd., Aptus Biotech S.L. (Spain), Base Pair Biotechnologies, Inc. (U.S.), NeoVentures Biotechnology, Inc. (Canada), SomaLogic, Inc. (U.S.), TriLink BioTechnologies, Inc. (U.S.), and Vivonics, Inc. (U.S.).

Aptamers Market

Source: MarketsandMarkets Analysis

Aptamers Market

Source: MarketsandMarkets Analysis

Aptamers Market

Source: MarketsandMarkets Analysis

Aptamers Market

Source: MarketsandMarkets Analysis

Aptamers Market

Source: MarketsandMarkets Analysis

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports